Hepion PharmaceuticalsHEPA +5.37% Market Cap is $1.57 Mil as of Jun. 28, 2026. The stock has 2 warning signs investors should review. Among 1,429 Biotechnology companies, Hepion Pharmaceuticals ranks worse than 96.64% on this metric.
Hepion Pharmaceuticals's quarterly market cap
increased
from Sep. 2025 ($0.58 Mil) to Dec. 2025 ($0.70 Mil) but then
declined
from Dec. 2025 ($0.70 Mil) to Mar. 2026 ($0.66 Mil).
Hepion Pharmaceuticals's annual market cap
declined
from Dec. 2023 ($15.55 Mil) to Dec. 2024 ($3.27 Mil) and
declined
from Dec. 2024 ($3.27 Mil) to Dec. 2025 ($0.70 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hepion Pharmaceuticals's Enterprise Value for Today is $1.49 Mil.
Hepion Pharmaceuticals (OTCPK:HEPA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Hepion Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hepion Pharmaceuticals Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hepion Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where Hepion Pharmaceuticals's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Hepion Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hepion Pharmaceuticals (HEPA) has a Market Cap of $1.57 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hepion Pharmaceuticals and its competitors. According to the industry distribution chart, Hepion Pharmaceuticals ranks #1381 out of 1429 companies in the Biotechnology industry, placing it in the top 96.6%.
Is Hepion Pharmaceuticals' Market Cap too high?
Hepion Pharmaceuticals' current Market Cap is $1.57 Mil. The Biotechnology industry median Market Cap is 112.70. Hepion Pharmaceuticals' value of $1.57 Mil is 98.6% below this industry median. Based on the distribution chart, Hepion Pharmaceuticals ranks #1381 out of 1429 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Hepion Pharmaceuticals' Market Cap compare to AXIM and SCNI?
According to the Biotechnology industry distribution chart, Hepion Pharmaceuticals ranks #1381 out of 1429 companies for Market Cap. This places Hepion Pharmaceuticals in the lower half of its industry. The industry median Market Cap is 112.70. Hepion Pharmaceuticals' value of $1.57 Mil is 98.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 112.70, based on 1,429 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hepion Pharmaceuticals's current Market Cap of $1.57 Mil is 98.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hepion Pharmaceuticals and its competitors. For the Biotechnology industry, the median Market Cap is 112.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hepion Pharmaceuticals's current Market Cap is $1.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hepion Pharmaceuticals stock overvalued right now?
Hepion Pharmaceuticals (HEPA) has a current Market Cap of $1.57 Mil. The current Market Cap is $1.57 Mil and 98.6% below the Biotechnology industry median of 112.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Hepion Pharmaceuticals (HEPA), the current Market Cap is $1.57 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of drug therapy for the treatment of chronic liver diseases. The company is pioneering early cancer detection solutions with a novel liquid biopsy. diagnostics. The company's mission is to redefine the early detection of hepatocellular carcinoma, moving from missed diagnoses to timely, precise intervention. It's focused on delivering non-invasive, clinically grounded liquid biopsy solutions for patients at the highest risk, particularly those living with cirrhosis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HEPA has been successfully added to your 